OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells presents a paramount challenge with the biopharmaceutical industry. A variety of strategies are employed enhance antibody titer, including process parameter optimization, media optimization, and adoption of perfusion systems. Fine-tuning growth parameters p